|
Prescription and Over-the-Counter Drug Product List
25th Edition
Cumulative Supplement Number 7: July 2006
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; CODEINE PHOSPHATE
SOLUTION; ORAL
ACETAMINOPHEN AND CODEINE PHOSPHATE
>A> AA + ACTAVIS MID 120MG/5ML;12MG/5ML N85861 001 Jul CAHN
>D> AA + ALPHARMA US 120MG/5ML;12MG/5ML N85861 001 Jul CAHN
SUSPENSION; ORAL
CAPITAL AND CODEINE
>A> AA ACTAVIS MID 120MG/5ML;12MG/5ML N85883 001 Jul CAHN
>D> AA ALPHARMA US 120MG/5ML;12MG/5ML N85883 001 Jul CAHN
TABLET; ORAL
>D> ACETAMINOPHEN W/ CODEINE NO. 3
>D> AA ROXANE 300MG;30MG N84656 001 Jul DISC
>A> @ 300MG;30MG N84656 001 Jul DISC
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
TABLET; ORAL
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>A> CORNERSTONE 325MG;100MG N76743 001 May 07, 2004 Jul CAHN
>A> AB 500MG;100MG N76750 001 Jun 28, 2004 Jul CAHN
>D> VINTAGE PHARMS 325MG;100MG N76743 001 May 07, 2004 Jul CAHN
>D> AB 500MG;100MG N76750 001 Jun 28, 2004 Jul CAHN
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE
TABLET; ORAL
ACETAMINOPHEN AND TRAMADOL HYDROCHLORIDE
>A> AB BARR 325MG;37.5MG N76914 001 Jul 26, 2006 Jul NEWA
ACETIC ACID, GLACIAL
SOLUTION/DROPS; OTIC
ACETASOL
>A> AT ACTAVIS MID 2% N87146 001 Jul CAHN
>D> AT ALPHARMA US 2% N87146 001 Jul CAHN
ACETIC ACID, GLACIAL; HYDROCORTISONE
SOLUTION/DROPS; OTIC
ACETASOL HC
>A> AT ACTAVIS MID 2%;1% N87143 001 Jan 13, 1982 Jul CAHN
>D> AT ALPHARMA US 2%;1% N87143 001 Jan 13, 1982 Jul CAHN
ACYCLOVIR
SUSPENSION; ORAL
ACYCLOVIR
>A> AB ACTAVIS MID 200MG/5ML N74738 001 Apr 28, 1997 Jul CAHN
>D> AB ALPHARMA US 200MG/5ML N74738 001 Apr 28, 1997 Jul CAHN
ALBUTEROL SULFATE
SOLUTION; INHALATION
ALBUTEROL SULFATE
>A> AN ACTAVIS MID EQ 0.083% BASE N73533 001 Sep 26, 1995 Jul CAHN
>D> AN ALPHARMA US EQ 0.083% BASE N73533 001 Sep 26, 1995 Jul CAHN
SYRUP; ORAL
ALBUTEROL SULFATE
>A> AA ACTAVIS MID EQ 2MG BASE/5ML N75262 001 Mar 30, 1999 Jul CAHN
>A> AA EQ 2MG BASE/5ML N74454 001 Sep 25, 1995 Jul CAHN
>D> AA ALPHARMA US EQ 2MG BASE/5ML N74454 001 Sep 25, 1995 Jul CAHN
>D> AA UDL EQ 2MG BASE/5ML N75262 001 Mar 30, 1999 Jul CAHN
ALPRAZOLAM
TABLET, EXTENDED RELEASE; ORAL
ALPRAZOLAM
>A> AB BARR 0.5MG N77725 001 Jul 31, 2006 Jul NEWA
>A> AB 1MG N77725 002 Jul 31, 2006 Jul NEWA
>A> AB 3MG N77725 003 Jul 31, 2006 Jul NEWA
AMANTADINE HYDROCHLORIDE
SYRUP; ORAL
AMANTADINE HYDROCHLORIDE
>A> AA + ACTAVIS MID 50MG/5ML N72655 001 Oct 30, 1990 Jul CAHN
>D> AA + ALPHARMA US 50MG/5ML N72655 001 Oct 30, 1990 Jul CAHN
AMINOPHYLLINE
SOLUTION; ORAL
AMINOPHYLLINE DYE FREE
>A> AA + ACTAVIS MID 105MG/5ML N87727 001 Apr 16, 1982 Jul CAHN
>D> AA + ALPHARMA US 105MG/5ML N87727 001 Apr 16, 1982 Jul CAHN
AMPICILLIN SODIUM; SULBACTAM SODIUM
INJECTABLE; INJECTION
AMPICILLIN AND SULBACTAM
>A> AP SANDOZ EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL N65310 001 Jul 25, 2006 Jul NEWA
>A> AP EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL N65241 001 Jul 25, 2006 Jul NEWA
>A> AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL N65310 002 Jul 25, 2006 Jul NEWA
>A> AP EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL N65241 002 Jul 25, 2006 Jul NEWA
>A> AP EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL N65240 001 Jul 25, 2006 Jul NEWA
ARIPIPRAZOLE
TABLET; ORAL
ABILIFY
>D> @ OTSUKA 2MG N21436 006 Nov 15, 2002 Jul CMFD
>A> 2MG N21436 006 Nov 15, 2002 Jul CMFD
BETAMETHASONE DIPROPIONATE
LOTION; TOPICAL
BETAMETHASONE DIPROPIONATE
>A> AB ACTAVIS MID EQ 0.05% BASE N70281 001 Jul 31, 1985 Jul CAHN
>D> AB ALPHARMA US EQ 0.05% BASE N70281 001 Jul 31, 1985 Jul CAHN
BETAMETHASONE VALERATE
LOTION; TOPICAL
BETAMETHASONE VALERATE
>A> AB ACTAVIS MID EQ 0.1% BASE N70052 001 Jul 31, 1985 Jul CAHN
>D> AB ALPHARMA US EQ 0.1% BASE N70052 001 Jul 31, 1985 Jul CAHN
BUDESONIDE
POWDER, METERED; INHALATION
>A> BUDESONIDE
>A> ASTRAZENECA 0.08MG/INH N21949 001 Jul 12, 2006 Jul NEWA
>A> + 0.16MG/INH N21949 002 Jul 12, 2006 Jul NEWA
>A> BUDESONIDE; FORMOTEROL FUMARATE
>A> SPRAY, METERED; INHALATION
>A> SYMBICORT
>A> ASTRAZENECA 0.08MG/INH;EQ 0.045MG BASE N21929 001 Jul 21, 2006 Jul NEWA
>A> + 0.016MG/INH;EQ 0.045MG BASE N21929 002 Jul 21, 2006 Jul NEWA
CARBAMAZEPINE
TABLET, CHEWABLE; ORAL
CARBAMAZEPINE
>A> AB JUBILANT PHARMS 100MG N71940 001 Feb 01, 1988 Jul CAHN
>D> AB WARNER CHILCOTT 100MG N71940 001 Feb 01, 1988 Jul CAHN
CEFADROXIL/CEFADROXIL HEMIHYDRATE
FOR SUSPENSION; ORAL
CEFADROXIL
>D> RANBAXY EQ 125MG BASE/5ML N65115 001 Mar 26, 2003 Jul CRLD
>A> + EQ 125MG BASE/5ML N65115 001 Mar 26, 2003 Jul CRLD
CEFDINIR
FOR SUSPENSION; ORAL
CEFDINIR
>A> AB LUPIN 125MG/5ML N65259 001 May 31, 2006 Jul CAHN
>D> AB LUPIN (USA) 125MG/5ML N65259 001 May 31, 2006 Jul CAHN
CHLORHEXIDINE GLUCONATE
SOLUTION; DENTAL
CHLORHEXIDINE GLUCONATE
>A> AT ACTAVIS MID 0.12% N74291 001 Dec 28, 1995 Jul CAHN
>D> AT ALPHARMA US 0.12% N74291 001 Dec 28, 1995 Jul CAHN
CHLOROPROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
NESACAINE
>A> + ABRAXIS BIOSCIENCE 1% N09435 001 Jul CAHN
>A> AP 2% N09435 002 Jul CAHN
>D> + ASTRAZENECA 1% N09435 001 Jul CAHN
>D> AP 2% N09435 002 Jul CAHN
NESACAINE-MPF
>A> @ ABRAXIS BIOSCIENCE 2% N09435 003 Jul CAHN
>A> AP + 2% N09435 006 May 02, 1996 Jul CAHN
>A> @ 3% N09435 004 Jul CAHN
>A> AP + 3% N09435 007 May 02, 1996 Jul CAHN
>D> @ ASTRAZENECA 2% N09435 003 Jul CAHN
>D> AP + 2% N09435 006 May 02, 1996 Jul CAHN
>D> @ 3% N09435 004 Jul CAHN
>D> AP + 3% N09435 007 May 02, 1996 Jul CAHN
CHLORPROMAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
CHLORPROMAZINE HYDROCHLORIDE
>A> AA ACTAVIS MID 100MG/ML N86863 001 Jul CAHN
>D> AA ALPHARMA US 100MG/ML N86863 001 Jul CAHN
CIMETIDINE HYDROCHLORIDE
SOLUTION; ORAL
CIMETIDINE HYDROCHLORIDE
>A> AA + ACTAVIS MID EQ 300MG BASE/5ML N74176 001 Jun 01, 1994 Jul CAHN
>D> AA + ALPHARMA US EQ 300MG BASE/5ML N74176 001 Jun 01, 1994 Jul CAHN
CLEMASTINE FUMARATE
SYRUP; ORAL
CLEMASTINE FUMARATE
>A> AA ACTAVIS MID EQ 0.5MG BASE/5ML N74075 001 Oct 31, 1993 Jul CAHN
>D> AA ALPHARMA US EQ 0.5MG BASE/5ML N74075 001 Oct 31, 1993 Jul CAHN
CLINDAMYCIN PHOSPHATE
SOLUTION; TOPICAL
CLINDAMYCIN PHOSPHATE
>A> AT ACTAVIS MID EQ 1% BASE N62811 001 Sep 01, 1988 Jul CAHN
>D> AT ALPHARMA US EQ 1% BASE N62811 001 Sep 01, 1988 Jul CAHN
CLOBETASOL PROPIONATE
SOLUTION; TOPICAL
CLOBETASOL PROPIONATE
>A> AT ACTAVIS MID 0.05% N74331 001 Dec 15, 1995 Jul CAHN
>D> AT ALPHARMA US 0.05% N74331 001 Dec 15, 1995 Jul CAHN
CLOZAPINE
TABLET, ORALLY DISINTEGRATING; ORAL
FAZACLO ODT
>D> ALAMO PHARMS 25MG N21590 001 Feb 10, 2004 Jul CAHN
>D> 50MG N21590 003 Jun 03, 2005 Jul CAHN
>D> + 100MG N21590 002 Feb 10, 2004 Jul CAHN
>A> AVANIR PHARMS 25MG N21590 001 Feb 10, 2004 Jul CAHN
>A> 50MG N21590 003 Jun 03, 2005 Jul CAHN
>A> + 100MG N21590 002 Feb 10, 2004 Jul CAHN
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PROMETH VC W/ CODEINE
>A> + ACTAVIS MID 10MG/5ML;5MG/5ML;6.25MG/5ML N88764 001 Oct 31, 1984 Jul CAHN
>D> + ALPHARMA US 10MG/5ML;5MG/5ML;6.25MG/5ML N88764 001 Oct 31, 1984 Jul CAHN
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PROMETH W/ CODEINE
>A> AA + ACTAVIS MID 10MG/5ML;6.25MG/5ML N88763 001 Oct 31, 1984 Jul CAHN
>D> AA + ALPHARMA US 10MG/5ML;6.25MG/5ML N88763 001 Oct 31, 1984 Jul CAHN
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
SYRUP; ORAL
TRIACIN-C
>A> AA ACTAVIS MID 10MG/5ML;30MG/5ML;1.25MG/5ML N88704 001 Mar 22, 1985 Jul CAHN
>D> AA ALPHARMA US 10MG/5ML;30MG/5ML;1.25MG/5ML N88704 001 Mar 22, 1985 Jul CAHN
CROMOLYN SODIUM
SOLUTION; INHALATION
CROMOLYN SODIUM
>A> AN ACTAVIS MID 10MG/ML N75067 001 Jul 19, 1999 Jul CAHN
>D> AN ALPHARMA US 10MG/ML N75067 001 Jul 19, 1999 Jul CAHN
CYPROHEPTADINE HYDROCHLORIDE
SYRUP; ORAL
CYPROHEPTADINE HYDROCHLORIDE
>A> AA + ACTAVIS MID 2MG/5ML N86833 001 Jul CAHN
>D> AA + ALPHARMA US 2MG/5ML N86833 001 Jul CAHN
DEXAMETHASONE
ELIXIR; ORAL
DEXAMETHASONE
>A> AA + ACTAVIS MID 0.5MG/5ML N84754 001 Jul CAHN
>D> AA + ALPHARMA US 0.5MG/5ML N84754 001 Jul CAHN
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PROMETH W/ DEXTROMETHORPHAN
>A> AA + ACTAVIS MID 15MG/5ML;6.25MG/5ML N88762 001 Oct 31, 1984 Jul CAHN
>D> AA + ALPHARMA US 15MG/5ML;6.25MG/5ML N88762 001 Oct 31, 1984 Jul CAHN
DIMETHYL SULFOXIDE
SOLUTION; INTRAVESICAL
RIMSO-50
>A> AT + BIONICHE PHARMA 50% N17788 001 Jul CAHN
>D> AT + EDWARDS 50% N17788 001 Jul CAHN
DIPYRIDAMOLE
TABLET; ORAL
DIPYRIDAMOLE
>D> @ CLONMEL HLTHCARE 25MG N88999 001 Feb 05, 1991 Jul CAHN
>D> AB 50MG N89000 001 Feb 05, 1991 Jul CAHN
>D> @ 75MG N89001 001 Feb 05, 1991 Jul CAHN
>A> @ GLENMARK PHARMA 25MG N88999 001 Feb 05, 1991 Jul CAHN
>A> AB 50MG N89000 001 Feb 05, 1991 Jul CAHN
>A> @ 75MG N89001 001 Feb 05, 1991 Jul CAHN
>A> EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
>A> TABLET; ORAL
>A> ATRIPLA
>A> + GILEAD 600MG;200MG;300MG N21937 001 Jul 12, 2006 Jul NEWA
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE W/ EPINEPHRINE
>A> AP + ABRAXIS BIOSCIENCE 0.005MG/ML;0.5% N06488 012 Jul CAHN
>A> AP + 0.005MG/ML;1% N06488 018 Nov 13, 1986 Jul CAHN
>A> AP + 0.005MG/ML;1.5% N06488 017 Jul CAHN
>A> AP + 0.005MG/ML;2% N06488 019 Nov 13, 1986 Jul CAHN
>A> AP + 0.01MG/ML;1% N06488 004 Jul CAHN
>A> @ 0.01MG/ML;2% N06488 003 Jul CAHN
>A> @ 0.02MG/ML;2% N06488 005 Jul CAHN
>D> AP + ASTRAZENECA 0.005MG/ML;0.5% N06488 012 Jul CAHN
>D> AP + 0.005MG/ML;1% N06488 018 Nov 13, 1986 Jul CAHN
>D> AP + 0.005MG/ML;1.5% N06488 017 Jul CAHN
>D> AP + 0.005MG/ML;2% N06488 019 Nov 13, 1986 Jul CAHN
>D> AP + 0.01MG/ML;1% N06488 004 Jul CAHN
>D> @ 0.01MG/ML;2% N06488 003 Jul CAHN
>D> @ 0.02MG/ML;2% N06488 005 Jul CAHN
ERYTHROMYCIN
SWAB; TOPICAL
ERYTHROMYCIN
>A> AT ALTANA 2% N65320 001 Jul 25, 2006 Jul NEWA
ESTRADIOL
FILM, EXTENDED RELEASE; TRANSDERMAL
CLIMARA
>D> BX + BERLEX 0.0375MG/24HR N20375 005 May 27, 2003 Jul CFTG
>A> AB + 0.0375MG/24HR N20375 005 May 27, 2003 Jul CFTG
>D> + 0.06MG/24HR N20375 006 May 27, 2003 Jul CFTG
>A> AB + 0.06MG/24HR N20375 006 May 27, 2003 Jul CFTG
ESTRADIOL
>A> AB MYLAN 0.0375MG/24HR N75182 004 Jul 20, 2006 Jul NEWA
>A> AB 0.06MG/24HR N75182 005 Jul 20, 2006 Jul NEWA
ETHACRYNATE SODIUM
INJECTABLE; INJECTION
EDECRIN
>A> + ATON EQ 50MG BASE/VIAL N16093 001 Jul CAHN
>D> + MERCK EQ 50MG BASE/VIAL N16093 001 Jul CAHN
>A> ETONOGESTREL
>A> IMPLANT; IMPLANTATION
>A> IMPLANON
>A> + ORGANON USA INC 68MG/IMPLANT N21529 001 Jul 17, 2006 Jul NEWA
FENTANYL
FILM, EXTENDED RELEASE; TRANSDERMAL
FENTANYL
>A> AB LAVIPHARM LABS 25UGM/HR N77051 001 Aug 04, 2006 Jul NEWA
>A> AB 50UGM/HR N77051 002 Aug 04, 2006 Jul NEWA
>A> AB 75UGM/HR N77051 003 Aug 04, 2006 Jul NEWA
>A> AB 100UGM/HR N77051 004 Aug 04, 2006 Jul NEWA
FENTANYL CITRATE
TROCHE/LOZENGE; ORAL
FENTANYL
>D> @ ANESTA EQ 0.1MG BASE N20195 007 Oct 30, 1995 Jul CAHN
>D> @ EQ 0.2MG BASE N20195 001 Oct 04, 1993 Jul CAHN
>D> @ EQ 0.3MG BASE N20195 002 Oct 04, 1993 Jul CAHN
>D> @ EQ 0.4MG BASE N20195 003 Oct 04, 1993 Jul CAHN
>A> @ CEPHALON EQ 0.1MG BASE N20195 007 Oct 30, 1995 Jul CAHN
>A> @ EQ 0.2MG BASE N20195 001 Oct 04, 1993 Jul CAHN
>A> @ EQ 0.3MG BASE N20195 002 Oct 04, 1993 Jul CAHN
>A> @ EQ 0.4MG BASE N20195 003 Oct 04, 1993 Jul CAHN
FINASTERIDE
TABLET; ORAL
FINASTERIDE
>A> AB DR REDDYS LABS INC 1MG N76436 001 Jul 28, 2006 Jul NEWA
PROPECIA
>D> + MERCK 1MG N20788 001 Dec 19, 1997 Jul CFTG
>A> AB + 1MG N20788 001 Dec 19, 1997 Jul CFTG
FLUNISOLIDE
SPRAY, METERED; NASAL
FLUNISOLIDE
>D> + BAUSCH AND LOMB 0.025MG/SPRAY N74805 001 Feb 20, 2002 Jul CTEC
>A> AB + 0.025MG/SPRAY N74805 001 Feb 20, 2002 Jul CTEC
>A> AB QPHARMA 0.025MG/SPRAY N77704 001 Aug 03, 2006 Jul NEWA
FLUOCINONIDE
SOLUTION; TOPICAL
FLUOCINONIDE
>A> AT ACTAVIS MID 0.05% N71535 001 Dec 02, 1988 Jul CAHN
>D> AT ALPHARMA US 0.05% N71535 001 Dec 02, 1988 Jul CAHN
FLUOXETINE HYDROCHLORIDE
SOLUTION; ORAL
FLUOXETINE
>A> AA ACTAVIS MID EQ 20MG BASE/5ML N75690 001 Jan 31, 2002 Jul CAHN
>D> AA ALPHARMA US EQ 20MG BASE/5ML N75690 001 Jan 31, 2002 Jul CAHN
FLUPHENAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
>D> PROLIXIN
>D> AA APOTHECON 5MG/ML N70533 001 Nov 07, 1985 Jul DISC
>A> @ 5MG/ML N70533 001 Nov 07, 1985 Jul DISC
FOLLITROPIN ALFA/BETA
INJECTABLE; SUBCUTANEOUS
FOLLISTIM AQ
>D> + ORGANON USA INC 150 IU/0.18ML N21211 003 Feb 11, 2004 Jul DISC
>A> @ 150 IU/0.18ML N21211 003 Feb 11, 2004 Jul DISC
>D> @ 300 IU/0.36ML N21211 001 Mar 23, 2004 Jul CMFD
>A> + 300 IU/0.36ML N21211 001 Mar 23, 2004 Jul CMFD
GEMFIBROZIL
TABLET; ORAL
GEMFIBROZIL
>A> AB INVAGEN PHARMS 600MG N77836 001 Jul 27, 2006 Jul NEWA
>A> GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
>A> TABLET; ORAL
>A> DUETACT
>A> TAKEDA GLOBAL 2MG;30MG N21925 001 Jul 28, 2006 Jul NEWA
>A> 4MG;30MG N21925 002 Jul 28, 2006 Jul NEWA
HALOPERIDOL LACTATE
SOLUTION; ORAL
HALOPERIDOL LACTATE
>A> ACTAVIS MID EQ 1MG BASE/ML N74536 001 Nov 02, 1995 Jul CAHN
>D> UDL EQ 1MG BASE/ML N74536 001 Nov 02, 1995 Jul CAHN
HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
SYRUP; ORAL
HYDROCODONE COMPOUND
>A> AA ACTAVIS MID 1.5MG/5ML;5MG/5ML N88017 001 Jul 05, 1983 Jul CAHN
>D> AA ALPHARMA US 1.5MG/5ML;5MG/5ML N88017 001 Jul 05, 1983 Jul CAHN
HYDROXYZINE HYDROCHLORIDE
SYRUP; ORAL
HYDROXYZINE HYDROCHLORIDE
>A> AA + ACTAVIS MID 10MG/5ML N86880 001 Jul CAHN
>D> AA + ALPHARMA US 10MG/5ML N86880 001 Jul CAHN
IBUPROFEN
SUSPENSION; ORAL
IBUPROFEN
>A> AB ACTAVIS MID 100MG/5ML N74978 001 Mar 25, 1998 Jul CAHN
>D> AB ALPHARMA US 100MG/5ML N74978 001 Mar 25, 1998 Jul CAHN
IPRATROPIUM BROMIDE
SOLUTION; INHALATION
IPRATROPIUM BROMIDE
>A> AN ACTAVIS MID 0.02% N75111 001 Apr 22, 1999 Jul CAHN
>D> AN ALPHARMA US 0.02% N75111 001 Apr 22, 1999 Jul CAHN
KETOCONAZOLE
>A> GEL; TOPICAL
>A> XOLEGEL
>A> + BARRIER THERAP 2% N21946 001 Jul 28, 2006 Jul NEWA
KETOPROFEN
CAPSULE; ORAL
KETOPROFEN
>D> AB CLONMEL HLTHCARE 25MG N74014 001 Jan 29, 1993 Jul CAHN
>D> AB 50MG N74014 002 Jan 29, 1993 Jul CAHN
>D> AB 75MG N74014 003 Jan 29, 1993 Jul CAHN
>A> AB RADIUS PHARMS 25MG N74014 001 Jan 29, 1993 Jul CAHN
>A> AB 50MG N74014 002 Jan 29, 1993 Jul CAHN
>A> AB 75MG N74014 003 Jan 29, 1993 Jul CAHN
LACTULOSE
SOLUTION; ORAL
CONSTULOSE
>A> AA + ACTAVIS MID 10GM/15ML N70288 001 Aug 15, 1988 Jul CAHN
>D> AA + ALPHARMA US 10GM/15ML N70288 001 Aug 15, 1988 Jul CAHN
SOLUTION; ORAL, RECTAL
ENULOSE
>A> AA + ACTAVIS MID 10GM/15ML N71548 001 Aug 15, 1988 Jul CAHN
>D> AA + ALPHARMA US 10GM/15ML N71548 001 Aug 15, 1988 Jul CAHN
LENALIDOMIDE
CAPSULE; ORAL
REVLIMID
>D> + CELGENE 10MG N21880 002 Dec 27, 2005 Jul CRLD
>A> 10MG N21880 002 Dec 27, 2005 Jul CRLD
>A> 15MG N21880 003 Jun 29, 2006 Jul NEWA
>A> + 25MG N21880 004 Jun 29, 2006 Jul NEWA
LEVETIRACETAM
>A> INJECTABLE; IV (INFUSION)
>A> KEPPRA
>A> + UCB INC 500MG/5ML (100MG/ML) N21872 001 Jul 31, 2006 Jul NEWA
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE
>A> AP + ABRAXIS BIOSCIENCE 0.5% N06488 008 Jul CAHN
>A> AP + 1% N06488 007 Jul CAHN
>A> AP + 1.5% N06488 010 Jul CAHN
>A> @ 2% N06488 002 Jul CAHN
>D> AP + ASTRAZENECA 0.5% N06488 008 Jul CAHN
>D> AP + 1% N06488 007 Jul CAHN
>D> AP + 1.5% N06488 010 Jul CAHN
>D> @ 2% N06488 002 Jul CAHN
XYLOCAINE 4% PRESERVATIVE FREE
>A> AP + ABRAXIS BIOSCIENCE 4% N10417 001 Jul CAHN
>D> AP + ASTRAZENECA 4% N10417 001 Jul CAHN
XYLOCAINE PRESERVATIVE FREE
>A> AP ABRAXIS BIOSCIENCE 1% N16801 005 Jan 19, 1988 Jul CAHN
>A> AP + 2% N16801 001 Jul CAHN
>A> AP 4% N16801 002 Jul CAHN
>A> AP + 10% N16801 003 Jul CAHN
>A> AP + 20% N16801 004 Jul CAHN
>D> AP ASTRAZENECA 1% N16801 005 Jan 19, 1988 Jul CAHN
>D> AP + 2% N16801 001 Jul CAHN
>D> AP 4% N16801 002 Jul CAHN
>D> AP + 10% N16801 003 Jul CAHN
>D> AP + 20% N16801 004 Jul CAHN
INJECTABLE; SPINAL
XYLOCAINE 1.5% W/ DEXTROSE 7.5%
>A> @ ABRAXIS BIOSCIENCE 1.5% N16297 001 Jul CAHN
>D> @ ASTRAZENECA 1.5% N16297 001 Jul CAHN
JELLY; TOPICAL
XYLOCAINE
>A> AT + ABRAXIS BIOSCIENCE 2% N08816 001 Jul CAHN
>D> AT + ASTRAZENECA 2% N08816 001 Jul CAHN
SOLUTION; ORAL
LIDOCAINE HYDROCHLORIDE VISCOUS
>A> AT ACTAVIS MID 2% N86578 001 Jul CAHN
>D> AT ALPHARMA US 2% N86578 001 Jul CAHN
XYLOCAINE VISCOUS
>A> AT + ABRAXIS BIOSCIENCE 2% N09470 001 Jul CAHN
>D> AT + ASTRAZENECA 2% N09470 001 Jul CAHN
SOLUTION; TOPICAL
XYLOCAINE 4% PRESERVATIVE FREE
>A> AT + ABRAXIS BIOSCIENCE 4% N10417 002 Jul CAHN
>D> AT + ASTRAZENECA 4% N10417 002 Jul CAHN
LIDOCAINE; PRILOCAINE
CREAM; TOPICAL
EMLA
>A> AB + ABRAXIS BIOSCIENCE 2.5%;2.5% N19941 001 Dec 30, 1992 Jul CAHN
>D> AB + ASTRAZENECA 2.5%;2.5% N19941 001 Dec 30, 1992 Jul CAHN
LINDANE
LOTION; TOPICAL
LINDANE
>A> AT + ACTAVIS MID 1% N87313 001 Jul CAHN
>D> AT + ALPHARMA US 1% N87313 001 Jul CAHN
SHAMPOO; TOPICAL
LINDANE
>A> AT + ACTAVIS MID 1% N87266 001 Jul CAHN
>D> AT + ALPHARMA US 1% N87266 001 Jul CAHN
LITHIUM CARBONATE
TABLET, EXTENDED RELEASE; ORAL
>D> ESKALITH CR
>D> AB + GLAXOSMITHKLINE 450MG N18152 001 Mar 29, 1982 Jul DISC
>A> @ 450MG N18152 001 Mar 29, 1982 Jul DISC
LITHIUM CARBONATE
>D> AB BARR 450MG N76366 001 Aug 21, 2003 Jul DISC
>A> @ 450MG N76366 001 Aug 21, 2003 Jul DISC
>D> AB ROXANE 450MG N76691 001 Jan 05, 2004 Jul CRLD
>A> AB + 450MG N76691 001 Jan 05, 2004 Jul CRLD
LOVASTATIN; NIACIN
TABLET, EXTENDED RELEASE; ORAL
ADVICOR
>A> + KOS LIFE 40MG;1GM N21249 004 Apr 27, 2006 Jul NEWA
>A> MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
>A> SOLUTION; INJECTION
>A> NORMOCARB HF 25
>A> + DIALYSIS SUPS 0.21GM/100ML;2.8GM/100ML;9.07GM/100 N21910 001 Jul 26, 2006 Jul NEWA
>A> NORMOCARB HF 35
>A> + DIALYSIS SUPS 0.21GM/100ML;3.97GM/100ML;8.3GM/100 N21910 002 Jul 26, 2006 Jul NEWA
MELOXICAM
TABLET; ORAL
>A> MELOXICAM
>A> AB ACTAVIS TOTOWA 7.5MG N77938 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77938 002 Jul 19, 2006 Jul NEWA
>A> AB APOTEX INC 7.5MG N77882 001 Jul 20, 2006 Jul NEWA
>A> AB 15MG N77882 002 Jul 20, 2006 Jul NEWA
>A> AB BRECKENRIDGE PHARM 7.5MG N77920 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77920 002 Jul 19, 2006 Jul NEWA
>A> AB CARACO 7.5MG N77937 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77937 002 Jul 19, 2006 Jul NEWA
>A> AB COREPHARMA 7.5MG N77930 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77930 002 Jul 19, 2006 Jul NEWA
>A> AB DR REDDYS LABS INC 7.5MG N77931 001 Jul 25, 2006 Jul NEWA
>A> AB 15MG N77931 002 Jul 25, 2006 Jul NEWA
>A> AB GENPHARM 7.5MG N77934 001 Jul 20, 2006 Jul NEWA
>A> AB 15MG N77934 002 Jul 20, 2006 Jul NEWA
>A> AB GLENMARK PHARMS 7.5MG N77932 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77932 002 Jul 19, 2006 Jul NEWA
>A> AB LUPIN PHARMS 7.5MG N77944 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77944 002 Jul 19, 2006 Jul NEWA
>A> AB MUTUAL PHARM 7.5MG N77935 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77935 002 Jul 19, 2006 Jul NEWA
>A> AB MYLAN 7.5MG N77923 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77923 002 Jul 19, 2006 Jul NEWA
>A> AB PAR PHARM 7.5MG N77933 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77933 002 Jul 19, 2006 Jul NEWA
>A> AB ROXANE 7.5MG N77925 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77925 002 Jul 19, 2006 Jul NEWA
>A> AB TEVA PHARMS 7.5MG N77936 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77936 002 Jul 19, 2006 Jul NEWA
>A> AB WATSON LABS 7.5MG N77929 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77929 002 Jul 19, 2006 Jul NEWA
>A> AB ZYDUS PHARMS USA 7.5MG N77921 001 Jul 19, 2006 Jul NEWA
>A> AB 15MG N77921 002 Jul 19, 2006 Jul NEWA
MOBIC
>D> BOEHRINGER 7.5MG N20938 001 Apr 13, 2000 Jul CFTG
>A> AB 7.5MG N20938 001 Apr 13, 2000 Jul CFTG
>D> + 15MG N20938 002 Aug 23, 2000 Jul CFTG
>A> AB + 15MG N20938 002 Aug 23, 2000 Jul CFTG
MESALAMINE
SUPPOSITORY; RECTAL
ROWASA
>A> @ ALAVEN PHARM 500MG N19919 001 Dec 18, 1990 Jul CAHN
>D> @ SOLVAY 500MG N19919 001 Dec 18, 1990 Jul CAHN
METFORMIN HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
METFORMIN HYDROCHLORIDE
>A> AB NOSTRUM 500MG N76756 001 Jul 26, 2006 Jul NEWA
TABLET; ORAL
METFORMIN HYDROCHLORIDE
>A> AB AMNEAL PHARM 500MG N77853 001 Jul 28, 2006 Jul NEWA
>A> AB 850MG N77853 002 Jul 28, 2006 Jul NEWA
>A> AB 1GM N77853 003 Jul 28, 2006 Jul NEWA
METHOTREXATE SODIUM
INJECTABLE; INJECTION
METHOTREXATE
>D> AP ABRAXIS PHARM EQ 250MG BASE/10ML (25MG/ML) N40263 002 Feb 26, 1999 Jul CRLD
>A> AP + EQ 250MG BASE/10ML (25MG/ML) N40263 002 Feb 26, 1999 Jul CRLD
METOCLOPRAMIDE HYDROCHLORIDE
SOLUTION; ORAL
METOCLOPRAMIDE HYDROCHLORIDE
>A> AA ACTAVIS MID EQ 5MG BASE/5ML N71340 001 Aug 18, 1988 Jul CAHN
>D> AA ALPHARMA US EQ 5MG BASE/5ML N71340 001 Aug 18, 1988 Jul CAHN
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL
>A> METOPROLOL SUCCINATE
>A> AB SANDOZ EQ 25MG TARTRATE N76969 001 Jul 31, 2006 Jul NEWA
TOPROL-XL
>D> ASTRAZENECA EQ 25MG TARTRATE N19962 004 Feb 05, 2001 Jul CFTG
>A> AB EQ 25MG TARTRATE N19962 004 Feb 05, 2001 Jul CFTG
METRONIDAZOLE
GEL; TOPICAL
METRONIDAZOLE
>A> AB TARO 0.75% N77819 001 Jul 18, 2006 Jul NEWA
NABUMETONE
TABLET; ORAL
NABUMETONE
>D> AB TEVA 750MG N75189 002 Sep 24, 2001 Jul CRLD
>A> AB + 750MG N75189 002 Sep 24, 2001 Jul CRLD
>D> RELAFEN
>D> AB SMITHKLINE BEECHAM 500MG N19583 001 Dec 24, 1991 Jul DISC
>A> @ 500MG N19583 001 Dec 24, 1991 Jul DISC
>D> AB + 750MG N19583 002 Dec 24, 1991 Jul DISC
>A> @ 750MG N19583 002 Dec 24, 1991 Jul DISC
NEOMYCIN SULFATE
TABLET; ORAL
NEOMYCIN SULFATE
>D> @ BRISTOL MYERS EQ 350MG BASE N60365 001 Jul CPOT
>A> @ 500MG N60365 001 Jul CPOT
>D> @ LANNETT EQ 350MG BASE N60607 001 Jul CPOT
>A> @ 500MG N60607 001 Jul CPOT
>D> @ LILLY EQ 350MG BASE N60385 001 Jul CPOT
>A> @ 500MG N60385 001 Jul CPOT
>D> @ ROXANE EQ 350MG BASE N62173 001 Jul CPOT
>A> @ 500MG N62173 001 Jul CPOT
>D> @ SANDOZ EQ 350MG BASE N61586 001 Jul CPOT
>A> @ 500MG N61586 001 Jul CPOT
>D> + TEVA EQ 350MG BASE N60304 001 Jul CFTG
>A> AB + 500MG N60304 001 Jul CFTG
>A> AB X GEN PHARMS 500MG N65220 001 Jul 28, 2006 Jul NEWA
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION; IRRIGATION
NEOMYCIN AND POLYMYXIN B SULFATE
>A> AT WATSON LABS EQ 40MG BASE/ML;200,000 UNITS/ML N62664 001 Apr 08, 1986 Jul CMFD
NEOMYCIN AND POLYMYXIN B SULFATES
>D> @ WATSON LABS EQ 40MG BASE/ML;200,000 UNITS/ML N62664 001 Apr 08, 1986 Jul CMFD
NYSTATIN
SUSPENSION; ORAL
NYSTATIN
>A> AA ACTAVIS MID 100,000 UNITS/ML N62349 001 Jul 14, 1982 Jul CAHN
>D> AA ALPHARMA US 100,000 UNITS/ML N62349 001 Jul 14, 1982 Jul CAHN
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; ORAL
PENTOXIFYLLINE
>D> AB CLONMEL HLTHCARE 400MG N74877 001 Jul 08, 1997 Jul CAHN
>A> AB RADIUS PHARMS 400MG N74877 001 Jul 08, 1997 Jul CAHN
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PROMETH VC PLAIN
>A> + ACTAVIS MID 5MG/5ML;6.25MG/5ML N88761 001 Nov 08, 1984 Jul CAHN
>D> + ALPHARMA US 5MG/5ML;6.25MG/5ML N88761 001 Nov 08, 1984 Jul CAHN
PHENYTOIN
SUSPENSION; ORAL
PHENYTOIN
>A> AB ACTAVIS MID 125MG/5ML N89892 001 Sep 25, 1992 Jul CAHN
>D> AB ALPHARMA US 125MG/5ML N89892 001 Sep 25, 1992 Jul CAHN
PRIMIDONE
TABLET; ORAL
PRIMIDONE
>A> AB WEST WARD 50MG N40667 001 Jul 27, 2006 Jul NEWA
>A> AB 250MG N40667 002 Jul 27, 2006 Jul NEWA
PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PROMETH PLAIN
>A> @ ACTAVIS MID 6.25MG/5ML N85953 001 Jul CAHN
>D> @ ALPHARMA US 6.25MG/5ML N85953 001 Jul CAHN
TABLET; ORAL
PROMETHAZINE HYDROCHLORIDE
>A> AB KVK-TECH INC 25MG N40712 001 Jul 31, 2006 Jul NEWA
>A> AB 50MG N40713 001 Jul 31, 2006 Jul NEWA
>A> AB VINTAGE PHARMS 12.5MG N40622 001 Jul 18, 2006 Jul NEWA
>A> AB 25MG N40622 002 Jul 18, 2006 Jul NEWA
>A> AB 50MG N40622 003 Jul 18, 2006 Jul NEWA
>D> ZYDUS PHARMS USA 12.5MG N40596 001 Nov 18, 2005 Jul CTEC
>A> AB 12.5MG N40596 001 Nov 18, 2005 Jul CTEC
PROPOFOL
INJECTABLE; INJECTION
DIPRIVAN
>A> @ ABRAXIS BIOSCIENCE 10MG/ML N19627 001 Oct 02, 1989 Jul CAHN
>A> AB + 10MG/ML N19627 002 Jun 11, 1996 Jul CAHN
>D> @ ASTRAZENECA 10MG/ML N19627 001 Oct 02, 1989 Jul CAHN
>D> AB + 10MG/ML N19627 002 Jun 11, 1996 Jul CAHN
QUINIDINE SULFATE
TABLET; ORAL
QUINIDINE SULFATE
>D> @ MUTUAL PHARM 300MG N81031 001 Apr 14, 1989 Jul CMFD
>A> AB 300MG N81031 001 Apr 14, 1989 Jul CMFD
>D> @ WATSON LABS 200MG N83288 001 Jul CMFD
>A> AB 200MG N83288 001 Jul CMFD
ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
INJECTABLE; INJECTION
NAROPIN
>A> ABRAXIS BIOSCIENCE 2MG/ML N20533 001 Sep 24, 1996 Jul CAHN
>A> 5MG/ML N20533 003 Sep 24, 1996 Jul CAHN
>A> 7.5MG/ML N20533 004 Sep 24, 1996 Jul CAHN
>A> + 10MG/ML N20533 005 Sep 24, 1996 Jul CAHN
>D> ASTRAZENECA 2MG/ML N20533 001 Sep 24, 1996 Jul CAHN
>D> 5MG/ML N20533 003 Sep 24, 1996 Jul CAHN
>D> 7.5MG/ML N20533 004 Sep 24, 1996 Jul CAHN
>D> + 10MG/ML N20533 005 Sep 24, 1996 Jul CAHN
SELENIUM SULFIDE
LOTION/SHAMPOO; TOPICAL
SELENIUM SULFIDE
>A> AT ACTAVIS MID 2.5% N84394 001 Jul CAHN
>D> AT ALPHARMA US 2.5% N84394 001 Jul CAHN
SODIUM CHLORIDE
>A> INJECTABLE; INTRAVASCULAR
>A> SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
>A> + MALLINCKRODT 45MG/50ML (0.9MG/ML) N21569 001 Jul 27, 2006 Jul NEWA
>A> 112.5MG/125ML (0.9MG/ML) N21569 002 Jul 27, 2006 Jul NEWA
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
>D> NUTROPIN DEPOT
>D> + GENENTECH 13.5MG/VIAL N21075 001 Dec 22, 1999 Jul DISC
>A> @ 13.5MG/VIAL N21075 001 Dec 22, 1999 Jul DISC
>D> + 18MG/VIAL N21075 002 Dec 22, 1999 Jul DISC
>A> @ 18MG/VIAL N21075 002 Dec 22, 1999 Jul DISC
>D> + 22.5MG/VIAL N21075 003 Dec 22, 1999 Jul DISC
>A> @ 22.5MG/VIAL N21075 003 Dec 22, 1999 Jul DISC
SULFAMETHOXAZOLE; TRIMETHOPRIM
SUSPENSION; ORAL
SULFATRIM
>A> AB ACTAVIS MID 200MG/5ML;40MG/5ML N18615 002 Jan 07, 1983 Jul CAHN
>D> AB ALPHARMA US 200MG/5ML;40MG/5ML N18615 002 Jan 07, 1983 Jul CAHN
SULFATRIM PEDIATRIC
>A> AB ACTAVIS MID 200MG/5ML;40MG/5ML N18615 001 Jan 07, 1983 Jul CAHN
>D> AB ALPHARMA US 200MG/5ML;40MG/5ML N18615 001 Jan 07, 1983 Jul CAHN
SULINDAC
TABLET; ORAL
SULINDAC
>D> @ CLONMEL HLTHCARE 150MG N73261 001 Sep 06, 1991 Jul CAHN
>D> @ 200MG N73262 001 Sep 06, 1991 Jul CAHN
>A> @ RADIUS PHARMS 150MG N73261 001 Sep 06, 1991 Jul CAHN
>A> @ 200MG N73262 001 Sep 06, 1991 Jul CAHN
SUNITINIB MALATE
CAPSULE; ORAL
SUTENT
>A> CPPI CV EQ 12.5MG BASE N21938 001 Jan 26, 2006 Jul CAHN
>A> EQ 25MG BASE N21938 002 Jan 26, 2006 Jul CAHN
>A> + EQ 50MG BASE N21938 003 Jan 26, 2006 Jul CAHN
>D> PFIZER EQ 12.5MG BASE N21938 001 Jan 26, 2006 Jul CAHN
>D> EQ 25MG BASE N21938 002 Jan 26, 2006 Jul CAHN
>D> + EQ 50MG BASE N21938 003 Jan 26, 2006 Jul CAHN
TAMOXIFEN CITRATE
SOLUTION; ORAL
SOLTAMOX
>D> + SAVIENT PHARMA EQ 10MG BASE/5ML N21807 001 Oct 29, 2005 Jul CAHN
>A> + SAVIENT PHARMS EQ 10MG BASE/5ML N21807 001 Oct 29, 2005 Jul CAHN
TERCONAZOLE
CREAM; VAGINAL
>D> TERAZOL 3
>D> AB + ORTHO MCNEIL 0.8% N19964 001 Feb 21, 1991 Jul DISC
>A> @ 0.8% N19964 001 Feb 21, 1991 Jul DISC
>D> TERAZOL 7
>D> AB + ORTHO MCNEIL 0.4% N19579 001 Dec 31, 1987 Jul DISC
>A> @ 0.4% N19579 001 Dec 31, 1987 Jul DISC
TERCONAZOLE
>D> AB TARO 0.4% N76043 001 Jan 19, 2005 Jul CRLD
>A> AB + 0.4% N76043 001 Jan 19, 2005 Jul CRLD
>D> AB 0.8% N75953 001 Apr 06, 2004 Jul CRLD
>A> BX + 0.8% N75953 001 Apr 06, 2004 Jul CRLD
THEOPHYLLINE
ELIXIR; ORAL
THEOPHYLLINE
>A> AA ACTAVIS MID 80MG/15ML N85863 001 Jul CAHN
>D> AA ALPHARMA US 80MG/15ML N85863 001 Jul CAHN
THIORIDAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
THIORIDAZINE HYDROCHLORIDE
>A> AA ACTAVIS MID 100MG/ML N88229 001 Aug 23, 1983 Jul CAHN
>D> AA ALPHARMA US 100MG/ML N88229 001 Aug 23, 1983 Jul CAHN
TOBRAMYCIN
SOLUTION; INHALATION
TOBI
>D> + CHIRON 300MG/5ML N50753 001 Dec 22, 1997 Jul CAHN
>A> + NOVARTIS PHARMS 300MG/5ML N50753 001 Dec 22, 1997 Jul CAHN
TOBRAMYCIN SULFATE
INJECTABLE; INJECTION
TOBRAMYCIN
>D> AP ABRAXIS PHARM EQ 40MG BASE/ML N65122 002 Nov 29, 2002 Jul CRLD
>A> AP + EQ 40MG BASE/ML N65122 002 Nov 29, 2002 Jul CRLD
TRIMIPRAMINE MALEATE
CAPSULE; ORAL
SURMONTIL
>D> ODYSSEY PHARMS EQ 25MG BASE N16792 001 Jul CFTG
>A> AB EQ 25MG BASE N16792 001 Jul CFTG
>D> EQ 50MG BASE N16792 002 Jul CFTG
>A> AB EQ 50MG BASE N16792 002 Jul CFTG
>D> + EQ 100MG BASE N16792 003 Sep 15, 1982 Jul CFTG
>A> AB + EQ 100MG BASE N16792 003 Sep 15, 1982 Jul CFTG
>A> TRIMIPRAMINE MALEATE
>A> AB ACTAVIS TOTOWA EQ 25MG BASE N77361 001 Aug 02, 2006 Jul NEWA
>A> AB EQ 50MG BASE N77361 002 Aug 02, 2006 Jul NEWA
>A> AB EQ 100MG BASE N77361 003 Aug 02, 2006 Jul NEWA
URSODIOL
CAPSULE; ORAL
URSODIOL
>A> AB COREPHARMA 300MG N77895 001 Jul 27, 2006 Jul NEWA
VALRUBICIN
SOLUTION; INTRAVESICAL
VALSTAR PRESERVATIVE FREE
>D> + ANTHRA 40MG/ML N20892 001 Sep 25, 1998 Jul CAHN
>A> + VALERA 40MG/ML N20892 001 Sep 25, 1998 Jul CAHN
VARENICLINE TARTRATE
TABLET; ORAL
CHANTIX
>A> CPPI CV EQ 0.5MG BASE N21928 001 May 10, 2006 Jul CAHN
>A> + EQ 1MG BASE N21928 002 May 10, 2006 Jul CAHN
>D> PFIZER EQ 0.5MG BASE N21928 001 May 10, 2006 Jul CAHN
>D> + EQ 1MG BASE N21928 002 May 10, 2006 Jul CAHN
VENLAFAXINE HYDROCHLORIDE
TABLET; ORAL
EFFEXOR
>D> WYETH PHARMS INC EQ 25MG BASE N20151 002 Dec 28, 1993 Jul CFTG
>A> AB EQ 25MG BASE N20151 002 Dec 28, 1993 Jul CFTG
>D> EQ 37.5MG BASE N20151 006 Dec 28, 1993 Jul CFTG
>A> AB EQ 37.5MG BASE N20151 006 Dec 28, 1993 Jul CFTG
>D> + EQ 50MG BASE N20151 003 Dec 28, 1993 Jul CFTG
>A> AB + EQ 50MG BASE N20151 003 Dec 28, 1993 Jul CFTG
>D> EQ 75MG BASE N20151 004 Dec 28, 1993 Jul CFTG
>A> AB EQ 75MG BASE N20151 004 Dec 28, 1993 Jul CFTG
>D> EQ 100MG BASE N20151 005 Dec 28, 1993 Jul CFTG
>A> AB EQ 100MG BASE N20151 005 Dec 28, 1993 Jul CFTG
>A> VENLAFAXINE HYDROCHLORIDE
>A> AB TEVA EQ 25MG BASE N76690 001 Aug 03, 2006 Jul CTNA
>A> AB EQ 37.5MG BASE N76690 002 Aug 03, 2006 Jul NEWA
>A> AB EQ 50MG BASE N76690 003 Aug 03, 2006 Jul NEWA
>A> AB EQ 75MG BASE N76690 004 Aug 03, 2006 Jul CTNA
>A> AB EQ 100MG BASE N76690 005 Aug 03, 2006 Jul NEWA
VERAPAMIL HYDROCHLORIDE
TABLET; ORAL
VERAPAMIL HYDROCHLORIDE
>D> @ CLONMEL HLTHCARE 80MG N71880 001 Apr 05, 1988 Jul CAHN
>D> @ 120MG N71881 001 Apr 05, 1988 Jul CAHN
>A> @ RADIUS PHARMS 80MG N71880 001 Apr 05, 1988 Jul CAHN
>A> @ 120MG N71881 001 Apr 05, 1988 Jul CAHN
ZONISAMIDE
CAPSULE; ORAL
ZONISAMIDE
>A> AB WOCKHARDT 25MG N77636 003 Jul 27, 2006 Jul NEWA
>A> AB 50MG N77636 002 Jul 27, 2006 Jul NEWA
>A> AVOBENZONE; ECAMSULE; OCTOCRYLENE
>A> CREAM; TOPICAL
>A> ANTHELIOS SX
>A> + LOREAL USA 2%;2%;10% N21502 001 Jul 21, 2006 Jul NEWA
CROMOLYN SODIUM
SPRAY, METERED; NASAL
CROMOLYN SODIUM
>A> ACTAVIS MID 5.2MG/SPRAY N74800 001 Jul 26, 2001 Jul CAHN
>D> ALPHARMA US 5.2MG/SPRAY N74800 001 Jul 26, 2001 Jul CAHN
IBUPROFEN
SUSPENSION; ORAL
CHILDREN'S ELIXSURE
>A> ALTERNA-TCHP LLC 100MG/5ML N21604 001 Jan 07, 2004 Jul CAHN
>D> TARO 100MG/5ML N21604 001 Jan 07, 2004 Jul CAHN
IBUPROFEN
>A> ACTAVIS MID 100MG/5ML N74916 001 Apr 30, 1999 Jul CAHN
>D> ALPHARMA US 100MG/5ML N74916 001 Apr 30, 1999 Jul CAHN
MINOXIDIL
SOLUTION; TOPICAL
MINOXIDIL (FOR MEN)
>A> ACTAVIS MID 2% N74588 001 Apr 05, 1996 Jul CAHN
>D> ALPHARMA US 2% N74588 001 Apr 05, 1996 Jul CAHN
MINOXIDIL EXTRA STRENGTH (FOR MEN)
>A> ACTAVIS MID 5% N75518 001 Nov 17, 2000 Jul CAHN
>D> ALPHARMA US 5% N75518 001 Nov 17, 2000 Jul CAHN
NAPROXEN SODIUM
>D> CAPSULE; ORAL
>D> NAPROXEN SODIUM
>D> + BANNER PHARMACAPS EQ 200MG BASE N21920 001 Feb 17, 2006 Jul DISC
>A> @ EQ 200MG BASE N21920 001 Feb 17, 2006 Jul DISC
TERBINAFINE
>A> GEL; TOPICAL
>A> LAMISIL AT
>A> + NOVARTIS 1% N21958 001 Jul 24, 2006 Jul NEWA
Date created: July 14, 2006, Last updated: August 16, 2006 |
